Sanctions, currency volatility and long-running pressure on insurers have made medical treatment hard to access in Iran for years. Now, the war launched by the US and Israel appears to have deepened the strain by disrupting regional supply routes, damaging parts of Iran's health infrastructure and adding fresh pressure to an already fragile pharmaceutical market. The results are affecting everyday life for many Iranians: from patients searching multiple pharmacies for medicine to doctors